Evidence map›Paper›PMID 39746004›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Reply to Kaestner et al.: Activation of PIEZO1 is not significant for the passage of red blood cells through biomimetic splenic slits.

Alexis Moreau, François Yaya, Huijie Lu, Anagha Surendranath, Anne Charrier, Benoit Dehapiot, Emmanuèle Helfer, Annie Viallat, Zhangli Peng

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alexis MoreauCNRS, Centre Interdisciplinaire de Nanoscience de Marseille, Turing Centre for Living Systems, Aix Marseille Université, Marseille 13009, France.ORCID 0000-0002-0559-6179
François YayaCNRS, Centre Interdisciplinaire de Nanoscience de Marseille, Turing Centre for Living Systems, Aix Marseille Université, Marseille 13009, France.
Huijie LuRichard and Loan Hill Department of Biomedical Engineering, University of Illinois, Chicago, IL 60612.
Anagha SurendranathCNRS, Centre Interdisciplinaire de Nanoscience de Marseille, Turing Centre for Living Systems, Aix Marseille Université, Marseille 13009, France.ORCID 0009-0001-1307-6552
Anne CharrierCNRS, Centre Interdisciplinaire de Nanoscience de Marseille, Turing Centre for Living Systems, Aix Marseille Université, Marseille 13009, France.ORCID 0000-0002-0205-1341
Benoit DehapiotCNRS, Institut de Biologie du Développement de Marseille, Turing Centre for Living Systems, Aix Marseille Université, Marseille 13009, France.ORCID 0000-0002-7559-5497
Emmanuèle HelferCNRS, Centre Interdisciplinaire de Nanoscience de Marseille, Turing Centre for Living Systems, Aix Marseille Université, Marseille 13009, France.ORCID 0000-0001-8123-0964
Annie ViallatCNRS, Centre Interdisciplinaire de Nanoscience de Marseille, Turing Centre for Living Systems, Aix Marseille Université, Marseille 13009, France.ORCID 0000-0001-5802-269X
Zhangli PengRichard and Loan Hill Department of Biomedical Engineering, University of Illinois, Chicago, IL 60612.ORCID 0000-0002-1506-2365

Funding

Agence Nationale de la Recherche (ANR) ANR-16-CONV-0001 and ANR-20-CE17- 0024NSF (NSF) CBET-1706436/1948347 DMS-1951526 NSF-PHY2210366
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39746004
PMCPMC11745357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.